Cargando…
Treatment of pretibial myxedema with intralesional immunomodulating therapy
OBJECTIVE: Local immune regulation therapy has been one of the therapeutic methods used for the treatment of autoimmune thyroid disease in patients with pretibial myxedema (PTM). However, the poor response rate and high recurrence rate are still major problems. Whether a premixed corticosteroid, com...
Autores principales: | Ren, Ziwei, He, Min, Deng, Fang, Chen, Yan, Chai, Liyin, Chen, Bing, Deng, Wuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598751/ https://www.ncbi.nlm.nih.gov/pubmed/28932121 http://dx.doi.org/10.2147/TCRM.S143711 |
Ejemplares similares
-
Pretibial myxedema successfully treated with intralesional hyaluronidase
por: Hoesly, Paul M., et al.
Publicado: (2018) -
Pretibial myxedema treated with intralesional hyaluronidase and triamcinolone
por: Kudlak, Natalie, et al.
Publicado: (2020) -
A Randomized Controlled Trial of Intralesional Glucocorticoid for Treating Pretibial Myxedema
por: Lan, Changgui, et al.
Publicado: (2015) -
Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature
por: Zhang, Fan, et al.
Publicado: (2018) -
A Case of Elephantiasic Pretibial Myxedema Successfully Treated With Intralesional Triamcinolone Acetate
por: Hathi, Deep, et al.
Publicado: (2022)